Anticoagulants, antiplatelets, and thrombolytics
著者
書誌事項
Anticoagulants, antiplatelets, and thrombolytics
(Methods in molecular medicine / John M. Walker, series editor, 93)
Humana Press, c2004
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This collection of review articles highlights the latest development of antithrombotics and provides proven experimental methods for the further development of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such antithrombin agents as the hirudin, and such antiplatelet drugs as the GPIIb/IIIa inhibitors and ADP receptor antagonists. Additional innovations discussed include aspirin and clopidogrel, the expanded use of polytherapeutic approaches, antiproteases (factors IIa, Xa, and VIIa), tissue factor targeting, platelet receptor targeting, and antithrombin III modulation.
目次
Highlights of Latest Advances in Antithrombotics Shaker A. Mousa Antiplatelet, Anticoagulant, and Thrombolytic Drug Interactions Omer Iqbal and Shaker A. Mousa Evaluation of Platelet Antagonists in In Vitro Flow Models of Thrombosis Owen J. T. McCarty, James P. Abulencia, Shaker A. Mousa, and Konstantinos Konstantopoulos Heparin and Low Molecular Weight Heparin in Thrombosis, Cancer, and Inflammatory Diseases Shaker A. Mousa Are Low Molecular Weight Heparins the Same? Shaker A. Mousa Antithrombotic Drugs for the Treatment of Heparin-Induced Thrombocytopenia Walter P. Jeske and Jeanine M. Walenga Laboratory Methods for Heparin-Induced Thrombocytopenia Margaret Prechel, Walter P. Jeske, and Jeanine M. Walenga Factor Xa Inhibitors Jeanine M. Walenga, Walter P. Jeske, Debra Hoppensteadt, and Jawed Fareed Tissue Factor/VIIa in Thrombosis and Cancer Shaker A. Mousa Tissue Factor Pathway Inhibitor in Thrombosis and Beyond Shaker A. Mousa, Jawed Fareed, Omer Iqbal, and Brigitte Kaiser Cell Adhesion Molecules: Potential Therapeutic and Diagnostic Implications Shaker A. Mousa Development and Applications of Animal Models of Thrombosis Ronald J. Shebuski, Larry R. Bush, Alison Gagnon, Liguo Chi, and Robert J. Leadley, Jr. A Survey of Venous Thrombosis Models Walter P. Jeske, Omer Iqbal, Jawed Fareed, and Brigitte Kaiser Arixtra(R) (Fondaparinux Sodium) Shaker A. Mousa Oral Thrombin Inhibitor Ximelagatran Shaker A. Mousa Pharmacogenomics and Coagulation Disorders Omer Iqbal Guidelines for Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Hikmat Abdel-Razeq, Mohamad Qari, Jorgen Kristensen, Hussein Alizeidah, Faisal Al-Sayegh, Mahmoud Marashi, Abdulaziz Alzeer, Omar Al-Amoudi, Hatem Qutub, Abdel-Aziz Al-Humiadi, Steen Husted, and Shaker A. Mousa on behalf of the GCC Thrombosis Study Group Index
「Nielsen BookData」 より